Clinical Trials Browser

Phase 2 × Metastatic Breast Cancer in the Brain × pyrotinib × Clear all

NCT06475443 2024-06-26

Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCs

Phase 2 Not yet recruiting

Metastatic Breast Cancer in the Brain